Advertisement

Topics

Postmarketing Safety Reporting for Human Drug and Biological Products Including Vaccines

22:57 EDT 17 May 2019 | FDA

Draft Guidance for Industry: Postmarketing Safety Reporting for Human Drug and Biological Products Including Vaccines, CBER, Biologics

Original Article: Postmarketing Safety Reporting for Human Drug and Biological Products Including Vaccines

NEXT ARTICLE

More From BioPortfolio on "Postmarketing Safety Reporting for Human Drug and Biological Products Including Vaccines"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...